{"id": "VdjKyiUAAAAJ", "citedby": 3295, "citedby5y": 2822, "hindex": 27, "hindex5y": 26, "i10index": 42, "i10index5y": 35, "coauthors": [], "name": "Yizhou Dong", "affiliation": "The Ohio State University", "interests": ["drug delivery", "biomaterials", "cancer and genetic disorders"], "cites_per_year": {"2008": 11, "2009": 21, "2010": 34, "2011": 46, "2012": 68, "2013": 99, "2014": 160, "2015": 253, "2016": 373, "2017": 551, "2018": 671, "2019": 685, "2020": 285}, "publications": [{"bib": {"title": "Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo", "year": "2016"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:QIV2ME_5wuYC", "citedby": "486"}, {"bib": {"title": "In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight", "year": "2014"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:2osOgNQ5qMEC", "citedby": "407"}, {"bib": {"title": "Glucose-responsive microgels integrated with enzyme nanocapsules for closed-loop insulin delivery", "year": "2013"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:d1gkVwhDpl0C", "citedby": "270"}, {"bib": {"title": "Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates (vol 111, pg 3955, 2014)", "year": "2014"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:_Qo2XoVZTnwC", "citedby": "258"}, {"bib": {"title": "Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates", "year": "2014"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:qjMakFHDy7sC", "citedby": "258"}, {"bib": {"title": "Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation", "year": "2012"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:9yKSN-GCB0IC", "citedby": "252"}, {"bib": {"title": "Biosynthesis, total syntheses, and antitumor activity of tanshinones and their analogs as potential therapeutic agents", "year": "2011"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:u-x6o8ySG0sC", "citedby": "162"}, {"bib": {"title": "A highly efficient and direct approach for synthesis of enantiopure \u03b2-amino alcohols by reductive cross-coupling of chiral N-tert-Butanesulfinyl imines with aldehydes", "year": "2005"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:u5HHmVD_uO8C", "citedby": "116"}, {"bib": {"title": "A non-viral CRISPR/Cas9 delivery system for therapeutic gene targeting in vivo", "year": "2017"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:RHpTSmoSYBkC", "citedby": "109"}, {"bib": {"title": "Antitumor agents. 266. Design, synthesis, and biological evaluation of novel 2-(furan-2-yl) naphthalen-1-ol derivatives as potent and selective antibreast cancer agents", "year": "2009"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:UeHWp8X0CEIC", "citedby": "74"}, {"bib": {"title": "Dendrimer-inspired nanomaterials for the in vivo delivery of siRNA to lung vasculature", "year": "2015"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:UebtZRa9Y70C", "citedby": "66"}, {"bib": {"title": "An orthogonal array optimization of lipid-like nanoparticles for mRNA delivery in vivo", "year": "2015"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:3fE2CSJIrl8C", "citedby": "64"}, {"bib": {"title": "Injectable and Glucose-Responsive Hydrogels Based on Boronic Acid\u2013Glucose Complexation", "year": "2016"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:e5wmG9Sq2KIC", "citedby": "61"}, {"bib": {"title": "Antitumor agents. 272. Structure\u2212 Activity relationships and in vivo selective anti-breast cancer activity of novel neo-tanshinlactone analogues", "year": "2010"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:IjCSPb-OGe4C", "citedby": "61"}, {"bib": {"title": "Two-Photon Near Infrared Fluorescent Turn-On Probe Toward Cysteine and Its Imaging Applications", "year": "2016"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:TQgYirikUcIC", "citedby": "59"}, {"bib": {"title": "Design, synthesis, and preclinical evaluation of new 5, 6-(or 6, 7-) disubstituted-2-(fluorophenyl) quinolin-4-one derivatives as potent antitumor agents", "year": "2010"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:zYLM7Y9cAGgC", "citedby": "56"}, {"bib": {"title": "Poly (glycoamidoamine) Brushes Formulated Nanomaterials for Systemic siRNA and mRNA Delivery in Vivo", "year": "2016"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:hC7cP41nSMkC", "citedby": "51"}, {"bib": {"title": "Effects of Chemically Modified Messenger RNA on Protein Expression", "year": "2016"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:dhFuZR0502QC", "citedby": "47"}, {"bib": {"title": "Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof", "year": "2016"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:hqOjcs7Dif8C", "citedby": "44"}, {"bib": {"title": "Antitumor agents 278. 4-Amino-2H-benzo [h] chromen-2-one (ABO) analogs as potent in vitro anti-cancer agents", "year": "2010"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:Tyk-4Ss8FVUC", "citedby": "42"}, {"bib": {"title": "Lipid\u2010Like Nanomaterials for Simultaneous Gene Expression and Silencing In Vivo", "year": "2014"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:roLk4NBRz8UC", "citedby": "39"}, {"bib": {"title": "Engineering CRISPR\u2013Cpf1 crRNAs and mRNAs to maximize genome editing efficiency", "year": "2017"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:4JMBOYKVnBMC", "citedby": "38"}, {"bib": {"title": "1, 3, 5-triazinane-2, 4, 6-trione derivatives and uses thereof", "year": "2016"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:Zph67rFs4hoC", "citedby": "35"}, {"bib": {"title": "Antitumor Agents. Part 287. Substituted 4\u2010Amino\u20102H\u2010pyran\u20102\u2010one (APO) Analogues Reveal a New Scaffold from Neo\u2010Tanshinlactone with in vitro Anticancer Activity.", "year": "2011"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:ULOm3_A8WrAC", "citedby": "34"}, {"bib": {"title": "Antitumor agents 287. Substituted 4-amino-2H-pyran-2-one (APO) analogs reveal a new scaffold from neo-tanshinlactone with in vitro anticancer activity", "year": "2011"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:Y0pCki6q_DkC", "citedby": "34"}, {"bib": {"title": "Recent progress of research on herbal products used in traditional Chinese medicine: the herbs belonging to the Divine Husbandman's Herbal Foundation Canon (\u795e\u8fb2\u672c\u8349\u7d93 Sh\u00e9n \u2026", "year": "2012"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:WF5omc3nYNoC", "citedby": "32"}, {"bib": {"title": "Size, Shape, and Sequence-Dependent Immunogenicity of RNA Nanoparticles", "year": "2017"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:r0BpntZqJG4C", "citedby": "30"}, {"bib": {"title": "Effects of local structural transformation of lipid-like compounds on delivery of messenger RNA", "year": "2016"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:7PzlFSSx8tAC", "citedby": "29"}, {"bib": {"title": "Lipid\u2010Modified Aminoglycoside Derivatives for In Vivo siRNA Delivery", "year": "2013"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:ufrVoPGSRksC", "citedby": "28"}, {"bib": {"title": "Nanoscale platforms for messenger RNA delivery", "year": "2018"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:maZDTaKrznsC", "citedby": "27"}, {"bib": {"title": "Biodegradable amino-ester nanomaterials for Cas9 mRNA delivery in vitro and in vivo", "year": "2017"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:JV2RwH3_ST0C", "citedby": "26"}, {"bib": {"title": "Antitumor Agents. Part 269 Non\u2010aromatic Ring\u2010A Neotanshinlactone Analogue, TNO, as a New Class of Potent Antitumor Agents.", "year": "2010"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:KlAtU1dfN6UC", "citedby": "26"}, {"bib": {"title": "Antitumor agents 269. Non-aromatic ring-A neotanshinlactone analog, TNO, as a new class of potent antitumor agents", "year": "2009"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:W7OEmFMy1HYC", "citedby": "26"}, {"bib": {"title": "Antitumor agents 270. Novel substituted 6-phenyl-4H-furo [3, 2-c] pyran-4-one derivatives as potent and highly selective anti-breast cancer agents", "year": "2010"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:YsMSGLbcyi4C", "citedby": "24"}, {"bib": {"title": "Lipid formulations for delivery of messenger RNA", "year": "2018"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:GnPB-g6toBAC", "citedby": "23"}, {"bib": {"title": "Ratiometric fluorescent probes for capturing endogenous hypochlorous acid in the lungs of mice", "year": "2018"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:NMxIlDl6LWMC", "citedby": "23"}, {"bib": {"title": "Nucleic acid-mediated intracellular protein delivery by lipid-like nanoparticles", "year": "2014"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:0EnyYjriUFMC", "citedby": "20"}, {"bib": {"title": "Strategies, design, and chemistry in siRNA delivery systems", "year": "2019"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:RYcK_YlVTxYC", "citedby": "19"}, {"bib": {"title": "Design and assessment of engineered CRISPR\u2013Cpf1 and its use for genome editing", "year": "2018"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:k_IJM867U9cC", "citedby": "16"}, {"bib": {"title": "Dual-functional lipid-like nanoparticles for delivery of mRNA and MRI contrast agents", "year": "2016"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:R3hNpaxXUhUC", "citedby": "15"}, {"bib": {"title": "Antitumor agents 281. Design, synthesis, and biological activity of substituted 4-amino-7, 8, 9, 10-tetrahydro-2H-benzo [h] chromen-2-one analogs (ATBO) as potent in vitro \u2026", "year": "2011"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:eQOLeE2rZwMC", "citedby": "14"}, {"bib": {"title": "Antitumor agents 279. Structure\u2013activity relationship and in vivo studies of novel 2-(furan-2-yl) naphthalen-1-ol (FNO) analogs as potent and selective anti-breast cancer agents", "year": "2011"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:_FxGoFyzp5QC", "citedby": "12"}, {"bib": {"title": "Poly (glycoamidoamine) brush nanomaterials for systemic siRNA delivery in vivo", "year": "2017"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:mB3voiENLucC", "citedby": "11"}, {"bib": {"title": "Poly (glycoamidoamine) brush nanomaterials for systemic siRNA delivery in vivo", "year": "2016"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:M05iB0D1s5AC", "citedby": "11"}, {"bib": {"title": "Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof", "year": "2018"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:ldfaerwXgEUC", "citedby": "10"}, {"bib": {"title": "DYZ\u20102\u201090, a Novel Neo\u2010tanshinlactone Ring\u2010Opened Compound, Induces ERK\u2010Mediated Mitotic Arrest and Subsequent Apoptosis by Activating JNK in Human Colorectal Cancer Cells", "year": "2012"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:Se3iqnhoufwC", "citedby": "10"}, {"bib": {"title": "Antitumor Agents. 289. Design, Synthesis, and Anti-Breast Cancer Activity in Vivo of 4-Amino-2 H-benzo [h] chromen-2-one and 4-Amino-7, 8, 9, 10-tetrahydro-2 H-benzo [h \u2026", "year": "2012"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:LkGwnXOMwfcC", "citedby": "9"}, {"bib": {"title": "Lipid Polymer Hybrid Nanomaterials for mRNA Delivery"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:TFP_iSt0sucC", "citedby": "9"}, {"bib": {"title": "Synthetic Oligonucleotides Inhibit CRISPR-Cpf1-Mediated Genome Editing", "year": "2018"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:ns9cj8rnVeAC", "citedby": "7"}, {"bib": {"title": "Preparation and optimization of lipid-like nanoparticles for mRNA delivery", "year": "2017"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:M3NEmzRMIkIC", "citedby": "7"}, {"bib": {"title": "Lipid formulations for delivery of messenger rna", "year": "2014"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:MXK_kJrjxJIC", "citedby": "7"}, {"bib": {"title": "Design, synthesis and evaluation of anti-CD123 antibody drug conjugates", "year": "2016"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:HDshCWvjkbEC", "citedby": "5"}, {"bib": {"title": "Chemotherapy drugs derived nanoparticles encapsulating mRNA encoding tumor suppressor proteins to treat triple-negative breast cancer"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:BqipwSGYUEgC", "citedby": "5"}, {"bib": {"title": "Design, synthesis and evaluation of anti-CD38 antibody drug conjugate based on Daratumumab and maytansinoid", "year": "2019"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:NaGl4SEjCO4C", "citedby": "4"}, {"bib": {"title": "RNA delivery biomaterials for the treatment of genetic and rare diseases", "year": "2019"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:lSLTfruPkqcC", "citedby": "3"}, {"bib": {"title": "Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof", "year": "2018"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:blknAaTinKkC", "citedby": "3"}, {"bib": {"title": "Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis", "year": "2020"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:3s1wT3WcHBgC", "citedby": "2"}, {"bib": {"title": "Antibiotic-Derived Lipid Nanoparticles to Treat Intracellular Staphylococcus aureus", "year": "2019"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:YFjsv_pBGBYC", "citedby": "2"}, {"bib": {"title": "Lipid formulations for delivery of messenger rna", "year": "2017"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:isC4tDSrTZIC", "citedby": "2"}, {"bib": {"title": "Polymers, hydrogels, and uses thereof", "year": "2016"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:hFOr9nPyWt4C", "citedby": "2"}, {"bib": {"title": "Design, synthesis, and biological evaluation of novel neo-tanshinlactone analogues as potent and selective anti-breast cancer agents", "year": "2009"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:4TOpqqG69KYC", "citedby": "2"}, {"bib": {"title": "CRISPR-Cas12a Possess Unconventional DNase Activity that Can Be Inactivated by Synthetic Oligonucleotides", "year": "2020"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:ZHo1McVdvXMC", "citedby": "1"}, {"bib": {"title": "GlcNAc Conjugated Atorvastatin with Enhanced Water Solubility and Cellular Internalization", "year": "2017"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:bEWYMUwI8FkC", "citedby": "1"}, {"bib": {"title": "Co-delivery of mRNA and SPIONs through amino-ester nanomaterials"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:iH-uZ7U-co4C", "citedby": "1"}, {"bib": {"title": "Long-term storage of lipid-like nanoparticles for mRNA delivery", "year": "2020"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:4OULZ7Gr8RgC", "citedby": "0"}, {"bib": {"title": "Recent advances of antibody drug conjugates for clinical applications", "year": "2020"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:pqnbT2bcN3wC", "citedby": "0"}, {"bib": {"title": "Lipid formulations for delivery of messenger rna", "year": "2020"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:HoB7MX3m0LUC", "citedby": "0"}, {"bib": {"title": "Rational Design of Small Molecules to Enhance Genome Editing Efficiency by Selectively Targeting Distinct Functional States of CRISPR-Cas12a", "year": "2020"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:SeFeTyx0c_EC", "citedby": "0"}, {"bib": {"title": "Ultra-thermostable RNA nanoparticles for solubilizing and high-yield loading of paclitaxel for breast cancer therapy", "year": "2020"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:u_35RYKgDlwC", "citedby": "0"}, {"bib": {"title": "Modified nucleic acids, hybrid guide rnas, and uses thereof", "year": "2020"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:rO6llkc54NcC", "citedby": "0"}, {"bib": {"title": "Leveraging mRNAs sequences to express SARS-CoV-2 antigens in vivo", "year": "2020"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:g5m5HwL7SMYC", "citedby": "0"}, {"bib": {"title": "Strategies for the CRISPR-Based Therapeutics", "year": "2019"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:zA6iFVUQeVQC", "citedby": "0"}, {"bib": {"title": "Engineered guide rna and uses thereof", "year": "2019"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:35N4QoGY0k4C", "citedby": "0"}, {"bib": {"title": "Biodegradable amino-ester nanomaterials for nucleic acid delivery", "year": "2019"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:vV6vV6tmYwMC", "citedby": "0"}, {"bib": {"title": "Targeted delivery of atorvastatin via asialoglycoprotein receptor (ASGPR)", "year": "2019"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:hMod-77fHWUC", "citedby": "0"}, {"bib": {"title": "Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof", "year": "2019"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:RGFaLdJalmkC", "citedby": "0"}, {"bib": {"title": "Lipid formulations for delivery of messenger rna", "year": "2018"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:O3NaXMp0MMsC", "citedby": "0"}, {"bib": {"title": "Benzene-1, 3, 5-tricarboxamide derivatives and uses thereof", "year": "2018"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:J_g5lzvAfSwC", "citedby": "0"}, {"bib": {"title": "Modified cpf1 mrna, modified guide rna, and uses thereof", "year": "2017"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:70eg2SAEIzsC", "citedby": "0"}, {"bib": {"title": "Brush-poly (glycoamidoamine)-lipids and uses thereof", "year": "2015"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:-f6ydRqryjwC", "citedby": "0"}, {"bib": {"title": "Dendrimer-Inspired Nanomaterials for the in Vivo Delivery of siRNA to Lung Vasculature", "year": "2014"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:fPk4N6BV_jEC", "citedby": "0"}, {"bib": {"title": "Drug Delivery: Lipid\u2010Modified Aminoglycoside Derivatives for In Vivo siRNA Delivery (Adv. Mater. 33/2013)", "year": "2013"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:8k81kl-MbHgC", "citedby": "0"}, {"bib": {"title": "Substituted afpo (6-aryl-4h-furo [3, 2-c] pyran-4-one) derivatives as anti-cancer agents", "year": "2009"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:M3ejUd6NZC8C", "citedby": "0"}, {"bib": {"title": "Neo-tanshinlactone derivatives as potent and selective anti breast cancer agents", "year": "2009"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:kNdYIx-mwKoC", "citedby": "0"}, {"bib": {"title": "Design, Synthesis, and Biological Evaluation of Neo-tanshinlactone Analogues as Potent and Selective Anti-Breast Cancer Agents", "year": "2009"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:2P1L_qKh6hAC", "citedby": "0"}, {"bib": {"title": "Investigation of new neo-tanshinlactone analogs as potent and selective anti breast cancer clinical trials candidates", "year": "2009"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:5nxA0vEk-isC", "citedby": "0"}, {"bib": {"title": "Stereoselective Reductive Coupling of Chiral Sulfinyl Imines with Aldehydes", "year": "2005"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:_kc_bZDykSQC", "citedby": "0"}, {"bib": {"title": "Size, Shape, and Sequence-Dependent Immunogenicity of RNA Nanoparticles"}, "source": "citations", "id_citations": "VdjKyiUAAAAJ:j3f4tGmQtD8C", "citedby": "0"}]}